8,729 Shares in Monsanto Company (MON) Acquired by Vident Investment Advisory LLC
Vident Investment Advisory LLC bought a new position in shares of Monsanto Company (NYSE:MON) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 8,729 shares of the basic materials company’s stock, valued at approximately $1,046,000.
Several other institutional investors also recently bought and sold shares of the stock. Meyer Handelman Co. increased its holdings in Monsanto by 0.6% during the 3rd quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock valued at $14,923,000 after purchasing an additional 706 shares in the last quarter. Toronto Dominion Bank increased its holdings in Monsanto by 6.3% during the 3rd quarter. Toronto Dominion Bank now owns 1,014,313 shares of the basic materials company’s stock valued at $121,519,000 after purchasing an additional 59,750 shares in the last quarter. Nikko Asset Management Americas Inc. increased its holdings in Monsanto by 1.3% during the 2nd quarter. Nikko Asset Management Americas Inc. now owns 450,700 shares of the basic materials company’s stock valued at $53,345,000 after purchasing an additional 5,700 shares in the last quarter. Oakbrook Investments LLC increased its holdings in Monsanto by 7.4% during the 3rd quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock valued at $2,438,000 after purchasing an additional 1,400 shares in the last quarter. Finally, Aviva PLC increased its holdings in Monsanto by 1.2% during the 2nd quarter. Aviva PLC now owns 304,501 shares of the basic materials company’s stock valued at $36,052,000 after purchasing an additional 3,569 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.
Monsanto Company (MON) traded down $0.24 during midday trading on Friday, hitting $117.85. The stock had a trading volume of 1,385,700 shares, compared to its average volume of 1,976,619. The firm has a market cap of $51,983.22, a PE ratio of 21.35, a P/E/G ratio of 1.70 and a beta of 1.04. Monsanto Company has a one year low of $104.08 and a one year high of $122.79. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The company had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same period last year, the firm earned $0.07 EPS. equities research analysts forecast that Monsanto Company will post 5.74 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 annualized dividend and a dividend yield of 1.83%. Monsanto’s dividend payout ratio (DPR) is currently 42.27%.
In related news, VP Duraiswami Narain sold 2,860 shares of Monsanto stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.00, for a total transaction of $343,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the sale, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The disclosure for this sale can be found here. Insiders sold a total of 49,236 shares of company stock valued at $5,931,934 over the last three months. Insiders own 0.79% of the company’s stock.
A number of equities research analysts recently weighed in on the company. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a report on Monday. Royal Bank of Canada reaffirmed a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Wednesday, November 15th. Wells Fargo & Company raised their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Barclays reaffirmed an “equal weight” rating and set a $124.00 price target (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Twelve investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $124.61.
TRADEMARK VIOLATION WARNING: “8,729 Shares in Monsanto Company (MON) Acquired by Vident Investment Advisory LLC” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/8729-shares-in-monsanto-company-mon-acquired-by-vident-investment-advisory-llc/1765871.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with Analyst Ratings Network's FREE daily email newsletter.